These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2417050)

  • 1. Alpha 2-adrenoceptor agonists in the treatment of hypertension.
    Kaplan NM
    J Cardiovasc Pharmacol; 1985; 7 Suppl 8():S64-6. PubMed ID: 2417050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress in the treatment of essential hypertension.
    Sharma PL; Pandhi P
    Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23 Suppl 1():S54-61. PubMed ID: 2432023
    [No Abstract]   [Full Text] [Related]  

  • 3. The impact on serum lipids of combinations of diuretics and beta-blockers and of beta-blockers alone.
    Helgeland A
    J Cardiovasc Pharmacol; 1984; 6 Suppl 3():S474-6. PubMed ID: 6208414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical experiences in antihypertensive treatment with guanabenz or clonidine in combination with thiazide].
    Tschöpe W; Orth H; Ritz E
    Verh Dtsch Ges Inn Med; 1978; (84):820-4. PubMed ID: 369211
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of alpha-2 agonists on renal function in hypertensive humans.
    Goldberg M; Gehr M
    J Cardiovasc Pharmacol; 1985; 7 Suppl 8():S34-7. PubMed ID: 2417046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative antihypertensive effects of guanabenz and methyldopa.
    Walker BR; Deitch MW; Schneider BE; Hare LE
    Clin Ther; 1981; 4(4):275-84. PubMed ID: 7332915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Office management of hypertension.
    Finnerty FA
    Compr Ther; 1984 Feb; 10(2):16-21. PubMed ID: 6142783
    [No Abstract]   [Full Text] [Related]  

  • 8. Considerations on physiopathological approaches to the treatment of hypertension.
    Zanchetti A; Leonetti G; Morganti A; Terzoli L
    Clin Exp Pharmacol Physiol Suppl; 1978; 4():1-9. PubMed ID: 28189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological rationale for antihypertensive drug treatment.
    Prichard BN
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S6-17. PubMed ID: 2454370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of pharmacokinetics and pharmacodynamics of adrenoceptor agonists and antagonists as antihypertensive agents.
    Louis WJ; McNeil JJ; Anavekar SN; Conway EL; Workman B; Howes LG; Drummer OH; Jarrott B
    J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S100-3. PubMed ID: 2455158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacological basis of the symptomatic treatment of arterial hypertension. II. Antihypertensive agent combinations].
    Fournier A; Lagrue G; Schmitt H
    Nouv Presse Med; 1973 Nov; 2(39):2595-600. PubMed ID: 4152250
    [No Abstract]   [Full Text] [Related]  

  • 12. A comparative study of a new alpha-adrenoceptor agonist, guanfacine and alpha-methyldopa in the treatment of hypertension.
    Joshi RC; De A; Cameron EG
    Br J Clin Pract; 1984 Feb; 38(2):66-7, 71. PubMed ID: 6142723
    [No Abstract]   [Full Text] [Related]  

  • 13. Cost-minimization analysis of initial antihypertensive therapy in patients with mild-to-moderate essential diastolic hypertension.
    Hilleman DE; Mohiuddin SM; Lucas BD; Stading JA; Stoysich AM; Ryschon K
    Clin Ther; 1994; 16(1):88-102; discussion 87. PubMed ID: 7911403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Centrally acting antihypertensive agents: an update.
    Sica DA
    J Clin Hypertens (Greenwich); 2007 May; 9(5):399-405. PubMed ID: 17485976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha 1-blockade for the treatment of hypertension: a megastudy of terazosin in 2214 clinical practice settings.
    Itskovitz HD
    Clin Ther; 1994; 16(3):490-504. PubMed ID: 7923316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hypertension treatment in the elderly].
    Korn A
    Wien Med Wochenschr; 1981 Feb; 131(4):91-3. PubMed ID: 6112819
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of antihypertensive drugs on lipid metabolism.
    Leren P
    Clin Ther; 1987; 9(3):326-32. PubMed ID: 2886221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central and peripheral blockade of the sympathetic nervous system.
    Weber MA; Drayer JI
    Am J Med; 1984 Oct; 77(4A):110-8. PubMed ID: 6148889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of sympatholytic and vasodilator drugs.
    Moyer JH
    Pa Med; 1984 Jan; 87(1):34-42. PubMed ID: 6144088
    [No Abstract]   [Full Text] [Related]  

  • 20. [Letter: Diet and drugs in arterial hypertension].
    Trocme C
    Nouv Presse Med; 1974 Jan; 3(2):91. PubMed ID: 4150091
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.